Merck Receives FDA Priority Review to Expand Dangerous Gardasil Vaccine to Women and Men Ages 27 to 45

Share it with your friends Like

Thanks! Share it with your friends!

Close

By AdminM

Gardasil-needle-27-45

by Brian Shilhavy
Editor, Health Impact News

Gardasil vaccine manufacturer, Merck, announced earlier this month (June, 2018) that the U.S. Food and Drug Administration (FDA) has granted them a “Priority Review” to approve the dangerous and controversial Gardasil 9 vaccine to women and men, ages 27 to 45.

The Gardasil vaccine is currently approved for girls and boys, ages 9 through 26.

The request by Merck to expand its market to women and men, ages 27 to 45, and the FDA’s approval to grant it a Priority Review by October 6, 2018, follows 10 years after the FDA struck down …read more

Source: Health Impact News

    

  • Rating:
  • Views:361 views
  • Categories: Health